Immunotherapy resistance in colorectal cancer: therapeutic strategies and biomarker-guided approaches
{{output}}
Overcoming immunotherapy resistance remains a major challenge in colorectal cancer (CRC), particularly because most tumors are microsatellite stable/proficient mismatch repair (MSS/pMMR) and respond poorly to immune checkpoint inhibitors (ICIs). In contrast, d... ...
